These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3038722)

  • 1. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
    McDonald JA; Caruso L; Karayiannis P; Scully LJ; Harris JR; Forster GE; Thomas HC
    Hepatology; 1987; 7(4):719-23. PubMed ID: 3038722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers.
    Krogsgaard K; Lindhardt BO; Nielson JO; Andersson P; Kryger P; Aldershvile J; Gerstoft J; Pedersen C
    Hepatology; 1987; 7(1):37-41. PubMed ID: 3643160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous loss of HBeAg and the prevalence of HTLV-III/LAV infection in a cohort of homosexual hepatitis B virus carriers and the implications for antiviral therapy.
    Weller IV; Brown A; Morgan B; Hawkins A; Briggs M; Waite J; Cameron CH; Tedder R
    J Hepatol; 1986; 3 Suppl 2():S9-16. PubMed ID: 3298414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
    Brook MG; McDonald JA; Karayiannis P; Caruso L; Forster G; Harris JR; Thomas HC
    Gut; 1989 Aug; 30(8):1116-22. PubMed ID: 2670693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors.
    Brook MG; Karayiannis P; Thomas HC
    Hepatology; 1989 Nov; 10(5):761-3. PubMed ID: 2680866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.
    Carreño V; Porres JC; Mora I; Bartolomé J; Bas C; Gutiez J; Cortés J; Hernández Guio C
    Liver; 1987 Dec; 7(6):325-32. PubMed ID: 3437794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant leukocyte interferon treatment of chronic hepatitis B.
    Dusheiko G; Dibisceglie A; Bowyer S; Sachs E; Ritchie M; Schoub B; Kew M
    Hepatology; 1985; 5(4):556-60. PubMed ID: 4018728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.
    Brook MG; Chan G; Yap I; Karayiannis P; Lever AM; Jacyna M; Main J; Thomas HC
    BMJ; 1989 Sep; 299(6700):652-6. PubMed ID: 2508850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.
    Novick DM; Lok AS; Thomas HC
    J Hepatol; 1985; 1(1):29-35. PubMed ID: 2414358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastoid and recombinant alpha-A interferon therapy of chronic hepatitis B virus infection. The Royal Free Hospital experience.
    Thomas HC; Scully LJ; McDonald JA
    J Hepatol; 1986; 3 Suppl 2():S193-7. PubMed ID: 3298407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon.
    Hess G; Meyer zum Büschenfelde KH
    Immunobiology; 1986 Sep; 172(3-5):255-61. PubMed ID: 3643162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
    Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy.
    Saracco G; Mazzella G; Rosina F; Cancellieri C; Lattore V; Raise E; Rocca G; Giorda L; Verme G; Gasbarrini G
    Hepatology; 1989 Sep; 10(3):336-41. PubMed ID: 2668148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
    Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
    Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
    Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).
    Krogsgaard K; Bindslev N; Christensen E; Craxi A; Schlichting P; Schalm S; Carreno V; Trepo C; Gerken G; Thomas HC
    J Hepatol; 1994 Oct; 21(4):646-55. PubMed ID: 7814812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.